ACADIA Pharmaceuticals SWOT analysis mixed results for CNS drug stock
ASIMX Fund | USD 15.33 0.01 0.07% |
Slightly above 55% of Alger Smidcap's investor base is interested to short. The analysis of overall sentiment of trading Alger Smidcap Focus mutual fund suggests that many investors are impartial at this time. Alger Smidcap's investing sentiment can be driven by a variety of factors including economic data, Alger Smidcap's earnings reports, geopolitical events, and overall market trends.
Alger |
ACADIA Pharmaceuticals SWOT analysis mixed results for CNS drug stock
Read at investing.com
Alger Smidcap Fundamental Analysis
We analyze Alger Smidcap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alger Smidcap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alger Smidcap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Alger Smidcap is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Alger Smidcap Focus Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alger Smidcap mutual fund to make a market-neutral strategy. Peer analysis of Alger Smidcap could also be used in its relative valuation, which is a method of valuing Alger Smidcap by comparing valuation metrics with similar companies.
Peers
Alger Smidcap Related Equities
BIPIX | Biotechnology Ultrasector | 1.86 | ||||
RYCFX | Biotechnology Fund | 1.22 | ||||
USSCX | Science Technology | 0.71 | ||||
JAGTX | Janus Global | 1.07 | ||||
GISTX | Goldman Sachs | 1.20 | ||||
GITAX | Goldman Sachs | 1.20 | ||||
HTECX | Hennessy Technology | 1.20 | ||||
PGKCX | Pgim Jennison | 1.51 |
Other Information on Investing in Alger Mutual Fund
Alger Smidcap financial ratios help investors to determine whether Alger Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alger with respect to the benefits of owning Alger Smidcap security.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |